(Q43242639)

17 November 2017

1 reference

title

Epidermal growth factor in clinical practice - a review of its biological actions, clinical indications and safety implications (English)

1 reference

17 November 2017

1 reference

Jorge Berlanga-Acosta

1

1 reference

17 November 2017

Jorge Gavilondo-Cowley

2

1 reference

17 November 2017

Pedro López-Saura

3

1 reference

17 November 2017

Tania González-López

4

1 reference

17 November 2017

María D Castro-Santana

5

1 reference

17 November 2017

Ernesto López-Mola

6

1 reference

17 November 2017

Gerardo Guillén-Nieto

7

1 reference

17 November 2017

Luis Herrera-Martinez

8

1 reference

17 November 2017

publication date

1 October 2009

1 reference

International Wound Journal

17 November 2017

published in

1 reference

17 November 2017

volume

6

1 reference

17 November 2017

issue

5

1 reference

17 November 2017

page(s)

331-346

1 reference

Structure of a mouse submaxillary messenger RNA encoding epidermal growth factor and seven related proteins

17 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1742-481X.2009.00622.X

Growth factors and wound healing: biochemical properties of growth factors and their receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1742-481X.2009.00622.X

Growth factors: regulation of normal and neoplastic growth

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1742-481X.2009.00622.X

Treatment of recalcitrant lower extremity ulcers with topical becaplermin

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1742-481X.2009.00622.X

Recombinant human platelet-derived growth factor-BB (becaplermin) for healing chronic lower extremity diabetic ulcers: an open-label clinical evaluation of efficacy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1742-481X.2009.00622.X

Growth regulation of skin fibroblasts

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1742-481X.2009.00622.X

Induction of keratinocyte growth factor expression is reduced and delayed during wound healing in the genetically diabetic mouse

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1742-481X.2009.00622.X

Growth factors secreted by fibroblasts: role in healing diabetic foot ulcers

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1742-481X.2009.00622.X

Advanced glycation end product precursors impair epidermal growth factor receptor signaling.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1742-481X.2009.00622.X

Methylglyoxal administration induces diabetes-like microvascular changes and perturbs the healing process of cutaneous wounds.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1742-481X.2009.00622.X

HoxD3 expression and collagen synthesis in diabetic fibroblasts

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1742-481X.2009.00622.X

Clinical evaluation of recombinant human platelet-derived growth factor for the treatment of lower extremity ulcers

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1742-481X.2009.00622.X

Human epidermal growth factor enhances healing of diabetic foot ulcers.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1742-481X.2009.00622.X

Recombinant human epidermal growth factor (EGF) to enhance healing for diabetic foot ulcers.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1742-481X.2009.00622.X

A review of a bi-layered living cell treatment (Apligraf) in the treatment of venous leg ulcers and diabetic foot ulcers

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1742-481X.2009.00622.X

Epidermal growth factor intralesional infiltrations can prevent amputation in patients with advanced diabetic foot wounds.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1742-481X.2009.00622.X

Recombinant human epidermal growth factor (REGEN-D 150): effect on healing of diabetic foot ulcers.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1742-481X.2009.00622.X

Accelerating effects of epidermal growth factor on skin lesions of pemphigus vulgaris: a double-blind, randomized, controlled trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1742-481X.2009.00622.X

Intralesional administration of epidermal growth factor-based formulation (Heberprot-P) in chronic diabetic foot ulcer: treatment up to complete wound closure

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1742-481X.2009.00622.X

Effect of urogastrone in the Zollinger-Ellison syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1742-481X.2009.00622.X

Effect of urogastrone on gastric secretion and serum gastrin concentration in patients with duodenal ulceration

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1742-481X.2009.00622.X

UROGASTRONE/EPIDERMAL GROWTH FACTOR IN TREATMENT OF CONGENITAL MICROVILLOUS ATROPHY

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1742-481X.2009.00622.X

Gastric ulcer treatment with intravenous human epidermal growth factor: a double-blind controlled clinical study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1742-481X.2009.00622.X

Epidermal growth factor enemas with oral mesalamine for mild-to-moderate left-sided ulcerative colitis or proctitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1742-481X.2009.00622.X

A pilot study of the use of epidermal growth factor in pediatric short bowel syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1742-481X.2009.00622.X

The EGFR family and its ligands in human cancer. signalling mechanisms and therapeutic opportunities

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1742-481X.2009.00622.X

EGF-ERBB signalling: towards the systems level

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1742-481X.2009.00622.X

RhoB protects human keratinocytes from UVB-induced apoptosis through epidermal growth factor receptor signaling

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1742-481X.2009.00622.X

Cell migration is essential for sustained growth of keratinocyte colonies: the roles of transforming growth factor-alpha and epidermal growth factor

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1742-481X.2009.00622.X

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1742-481X.2009.00622.X

Ectodomain shedding of epidermal growth factor receptor ligands is required for keratinocyte migration in cutaneous wound healing

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1742-481X.2009.00622.X

The activity of collagenase-1 is required for keratinocyte migration on a type I collagen matrix

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1742-481X.2009.00622.X

The intracellular functions of alpha6beta4 integrin are regulated by EGF.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1742-481X.2009.00622.X

Biophysical integration of effects of epidermal growth factor and fibronectin on fibroblast migration

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1742-481X.2009.00622.X

Epidermal growth factor receptor distribution in burn wounds. Implications for growth factor-mediated repair

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1742-481X.2009.00622.X

The epidermal growth factor receptor system in skin repair and inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1742-481X.2009.00622.X

Putting tumours in context

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1742-481X.2009.00622.X

Sarcoma growth factor from conditioned medium of virally transformed cells is composed of both type alpha and type beta transforming growth factors

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1742-481X.2009.00622.X

Successful application of epidermal growth factor for treatment of hemorrhagic cystitis after bone marrow transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1742-481X.2009.00622.X

Epidermal growth factor receptor dependence in human tumors: more than just expression?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1742-481X.2009.00622.X

Role of epidermal growth factor and other growth factors in the prevention of necrotizing enterocolitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1742-481X.2009.00622.X

Effect of epidermal growth factor on ulcerative mucositis in hamsters that receive cancer chemotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1742-481X.2009.00622.X

Mucosal irritation, adaptive cytoprotection, and adaptation to topical ammonia in the rat stomach

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1742-481X.2009.00622.X

Epidermal growth factor inhibits growth of A431 human epidermoid carcinoma in serum-free cell culture

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1742-481X.2009.00622.X

Effects of longterm epidermal growth factor treatment on the normal rat colon

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1742-481X.2009.00622.X

Chronic systemic treatment with epidermal growth factor induces hypergastrinaemia in Goettingen minipigs.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1742-481X.2009.00622.X

Effect of local administration of epidermal growth factor on 9,10-dimethyl-1,2-benzanthracene-induced tumour formation in hamster cheek pouch.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1742-481X.2009.00622.X

Augmentation of chemically induced pancreatic and bronchial cancers by epidermal growth factor

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1742-481X.2009.00622.X

Signal transduction by receptors with tyrosine kinase activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1742-481X.2009.00622.X

Toxicokinetic study of recombinant human heparin-binding epidermal growth factor-like growth factor (rhHB-EGF) in female Sprague Dawley rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1742-481X.2009.00622.X

Construction of a novel oncogene based on synthetic sequences encoding epidermal growth factor.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1742-481X.2009.00622.X

Autocrine growth factors and cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1742-481X.2009.00622.X

A multihit, multistage model of chemical carcinogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1742-481X.2009.00622.X

Epidermal growth factor receptor-mediated activation of Stat3 during multistage skin carcinogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1742-481X.2009.00622.X

Targeting the EGFR, VEGFR, and PDGFR on colon cancer cells and stromal cells is required for therapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1742-481X.2009.00622.X

Burn scar neoplasms: a literature review and statistical analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1742-481X.2009.00622.X

10.1111/J.1742-481X.2009.00622.X

21 January 2018

Identifiers

DOI

1 reference

17 November 2017

1 reference